e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension
Rui Zhang, Xiao-Jian Wang, Hong-Da Zhang, Xiao-Qing Sun, Qin-Hua Zhao, Lan Wang, Jing He, Xin Jiang, Jin-Ming Liu and Zhi-Cheng Jing
Source:
Eur Respir J 2016; 48: 1386-1395
Journal Issue:
November
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rui Zhang, Xiao-Jian Wang, Hong-Da Zhang, Xiao-Qing Sun, Qin-Hua Zhao, Lan Wang, Jing He, Xin Jiang, Jin-Ming Liu and Zhi-Cheng Jing. Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2016; 48: 1386-1395
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Effect of the Asp
298
variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 547s
Year: 2006
Nitric oxide vs prostacyclin in chronic high-flow pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002
Nitric oxide in acute testing in patients with pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Upregulation of endothelial nitric oxide synthase in pulmonary artery of infants with pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 694s
Year: 2004
Tolerance of long term nitric oxide treatment in severe arterial pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 370s
Year: 2002
Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Physical training and metabolics of nitric oxide in individuals with idiopathic pulmonary arterial hypertension.
Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies
Year: 2019
Inhaled nitric oxide in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2006; 28: Suppl. 50, 399s
Year: 2006
Acute vasoresponsiveness to inhaled nitric oxide in sarcoidosis-associated pulmonary hypertension
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Pathways in pulmonary arterial hypertension: the future is here
Source: Eur Respir Rev 2012 21: 321-327
Year: 2012
Infused nitric oxide in experimental pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007
Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept